Frankfurt
23.09.26 | 08:11
7,500 Euro
+1,35 % +0,100
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 7,450 | 7,550 | 22:49 | |
| 7,450 | 7,550 | 22:00 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Full Transcript: Exagen Q2 2026 Earnings Call | 2 | Benzinga.com | ||
| 11.08. | Exagen auf Wachstumskonferenz von Canaccord Genuity: Turnaround gewinnt an Fahrt | 5 | Investing.com Deutsch | ||
| 04.08. | Exagen targets $72M-$75M 2026 revenue outlook as profitability nears breakeven | 4 | Seeking Alpha | ||
| 04.08. | Exagen Q2 2026 slides: record revenue, stock surges 30% on results | 2 | Investing.com | ||
| 04.08. | Exagen Q2 2026 slides: record revenue, stock surges 36% | 2 | Investing.com | ||
| 04.08. | EXAGEN INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 04.08. | Exagen GAAP EPS of -$0.13 beats by $0.06, revenue of $19.94M beats by $2.07M | 2 | Seeking Alpha | ||
| 04.08. | Exagen Inc. Reports Second Quarter 2026 Financial Results | 551 | GlobeNewswire (Europe) | Achieved record total revenue, test volume and trailing twelve-month ASP Reduced net loss by nearly 30% and narrowed adjusted EBITDA loss to $0.1 million Increased full-year revenue guidance to... ► Artikel lesen | |
| EXAGEN Aktie jetzt für 0€ handeln | |||||
| 04.08. | EXAGEN INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 21.07. | Exagen Inc.: Exagen to Announce Second Quarter Financial Results on August 4, 2026 | 1 | GlobeNewswire (USA) | ||
| 09.06. | EXAGEN INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.06. | Exagen Inc.: Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus | 1 | GlobeNewswire (USA) | ||
| 12.05. | BTIG senkt Kursziel für Exagen auf 8 US-Dollar, bestätigt aber 'Buy'-Rating | 6 | Investing.com Deutsch | ||
| 12.05. | Exagen stock price target lowered to $8 by BTIG on valuation | 1 | Investing.com | ||
| 12.05. | Exagen reaffirms $70M-$73M 2026 revenue guidance as it targets $600-$650 ASP over time | 1 | Seeking Alpha | ||
| 11.05. | Exagen Inc. (XGN) Reports Q1 Loss, Beats Revenue Estimates | 1 | Zacks | ||
| 11.05. | Exagen: EPS übertrifft Schätzungen um 0,05 $ - Umsatz besser als erwartet | 1 | Investing.com Deutsch | ||
| 11.05. | EXAGEN INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 11.05. | Exagen beats top-line and bottom-line estimates; reaffirms FY26 outlook | 1 | Seeking Alpha | ||
| 11.05. | Exagen Inc. Reports First Quarter 2026 Results | 289 | GlobeNewswire (Europe) | CARLSBAD, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2026... ► Artikel lesen |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,420 | -2,38 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| HIMS & HERS HEALTH | 25,000 | -5,94 % | ROUNDUP/Aktien New York Schluss: Chipwerte belasten Nasdaq | NEW YORK (dpa-AFX) - Technologieaktien haben am Montag in den USA wieder einmal geschwächelt. Standardwerte legten dagegen überwiegend moderat zu. Negative Vorgaben aus Asien, die am Mittwoch nachbörslich... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,064 | -0,31 % | Dr. Steven S. Sangha: Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc. | Toronto, Ontario--(Newsfile Corp. - September 11, 2026) - Steven Sangha announces he has entered into a voting and support agreement ("Voting Agreement") with Seraxis Holdings, Inc. ("Seraxis") in connection... ► Artikel lesen | |
| CERENOME | 1,674 | +1,33 % | Cerenome, Inc.: Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division | HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), today announces the appointment of Samantha... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,060 | +4,57 % | ATOSSA THERAPEUTICS, INC. - 8-K, Current Report | ||
| HENRY SCHEIN | 75,50 | -1,31 % | HENRY SCHEIN INC - 8-K, Current Report | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Historischer Wendepunkt - darum fliegt die Aktie! | Volltreffer: Bereits im Frühjahr hatte ich die positive Entwicklung bei Sonoma Pharmaceuticals antizipiert und die Nano-Cap-Aktie als hochinteressante Turnaround-Spekulation vorgestellt. Damals hatte... ► Artikel lesen | |
| TANDEM DIABETES | 14,000 | -8,50 % | Tandem Diabetes Care, Inc.: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets | Compatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,090 | +0,93 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| QUIDELORTHO | 9,482 | -0,92 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| AMBU | 8,995 | +3,33 % | Ambu A/S: Interim Report For Q3 | 25.8.2026 18:01:05 CEST | Ambu A/S |
Interim report (Q1 and Q3)
In Q3 2025/26, Ambu delivered organic revenue growth of 10.3%, driven by strong performance in Endoscopy Solutions growing 16.0% organically.... ► Artikel lesen | |
| VERU | 2,450 | 0,00 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| LIFEWARD | 7,000 | 0,00 % | Lifeward Ltd.: Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer | HUDSON, Mass. and YOKNEAM ILLIT, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 4,020 | -1,47 % | Clover Health Investments, Corp.: Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 | WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great... ► Artikel lesen | |
| SENSEONICS | 8,700 | -1,14 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen |
Das Unternehmen EXAGEN INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 7,500 Euro und damit +1,35 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXAGEN INC finden Sie auf Wallstreet Online.